Wai-Yip Lee
Director/Board Member bij Aptorum Therapeutics Ltd.
Profiel
Wai-Yip Lee is currently a Director at Aptorum Therapeutics Ltd.
He previously held positions as the Chief Executive Officer & Chief Scientific Officer at Aptorum Therapeutics Ltd.
from 2018 to 2019, Senior Scientist at Celgene Corp.
from 2008 to 2013, Principal Scientist at Novartis Pharmaceuticals Corp.
from 2003 to 2008, and Assistant Professor at The Chinese University of Hong Kong from 2013 to 2018.
Dr. Lee is also currently the Head-Research & Development at Aptorum Group Ltd.
from 2019 to 2023.
Dr. Lee obtained a doctorate degree from the University of Wisconsin in 2003 and an undergraduate degree from The Chinese University of Hong Kong in 1995.
Actieve functies van Wai-Yip Lee
| Bedrijven | Functie | Begin |
|---|---|---|
Aptorum Therapeutics Ltd.
 Aptorum Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Aptorum Therapeutics Ltd. manufactures pharmaceutical products. The company is headquartered in Hong Kong. | Director/Board Member | - |
Eerdere bekende functies van Wai-Yip Lee
| Bedrijven | Functie | Einde |
|---|---|---|
| APTORUM GROUP LIMITED | Chief Tech/Sci/R&D Officer | 01-06-2023 |
Aptorum Therapeutics Ltd.
Aptorum Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Aptorum Therapeutics Ltd. manufactures pharmaceutical products. The company is headquartered in Hong Kong. | Chief Executive Officer | 01-03-2019 |
| The Chinese University of Hong Kong | Corporate Officer/Principal | 01-01-2018 |
| CELGENE | Corporate Officer/Principal | 01-07-2013 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01-11-2008 |
Opleiding van Wai-Yip Lee
| University of Wisconsin | Doctorate Degree |
| The Chinese University of Hong Kong | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| APTORUM GROUP LIMITED | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Aptorum Therapeutics Ltd.
Aptorum Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Aptorum Therapeutics Ltd. manufactures pharmaceutical products. The company is headquartered in Hong Kong. | Health Technology |
